Russell W. Jenkins
0000-0001-6110-2148
Publication & Citation Trends
Publications
0 total
Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours.
Cited by 0
Semantic Scholar
Abstract 4128: Mapping the hypoxic regulation of IFNγ and TNFα-mediated kinase pathways in melanoma
Cited by 0
Semantic Scholar
Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity
Cited by 2
Semantic Scholar
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids.
Cited by 10
Semantic Scholar
LRP2 expression in melanoma is associated with a transitory cell state, increased T cell infiltration, and is upregulated by IFNγ signaling OA
Cited by 1
Semantic Scholar
Research Topics
CAR-T cell therapy research
(111)
Cancer Immunotherapy and Biomarkers
(74)
Immunotherapy and Immune Responses
(43)
Sphingolipid Metabolism and Signaling
(23)
Immune cells in cancer
(21)
Affiliations
Broad Institute
National Institutes of Health
Veterinary Medicines Directorate
Harvard University
Johns Hopkins University